Antoine Elias Karnoub

Va Boston Health Care System

$4,168,394

Attributed

$4,168,394

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $805.5K · FY2017–25

$1M$750K$500K$250K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,168,394 · 2

VA$0 · 1

By mechanism

R01$4,168,394 · 2

I01$0 · 1

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Tumor”

Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213

Research focus

TumorTumor InitiationSpecimenTherapeutic TargetMalignant NeoplasmsMalignant - DescriptorPre-Clinical ModelResistancePathogenesisTargeted TreatmentCohortIn VitroIn VivoMalignant Breast NeoplasmCancer Stem CellNeoplasm MetastasisBreast Cancer CellRecurrenceBiological MarkersClinicPathway InteractionsPre-ClinicalCancer CellPrognostic Marker